✦ LIBER ✦

Phase 2 Trial of Moderately High Dose Single Agent Mitoxantrone in Platinum and Paclitaxel-Refractory Ovarian Cancer

✍ Scribed by Maurie Markman; Stuart M. Lichtman; Howard Homesley; Alexander Kennedy; Kenneth Webster; Scott Ernst; George Omura; Jerome Belinson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 trial of single-agent gemcitabin

✍ Maurie Markman; Kenneth Webster; Kristine Zanotti; Barbara Kulp; Gertrude Peters 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Phase 2 trial of single agent docetaxel

✍ Maurie Markman; Kristine Zanotti; Kenneth Webster; Gertrude Peterson; Barbara Ku 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Phase 2 Trial of Single Agent Ifosfamide

✍ Maurie Markman; Alexander Kennedy; Gregory Sutton; Jean Hurteau; Kenneth Webster 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Phase 2 Trial of Liposomal Doxorubicin (

✍ Maurie Markman; Alexander Kennedy; Kenneth Webster; Gertrude Peterson; Barbara K 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Phase II trial of single agent carboplat

✍ Maurie Markman; Tracy Glass; Harriet O Smith; Kenneth D Hatch; Geoffrey R Weiss; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Phase 2 study of canfosfamide in combina

✍ John J Kavanagh; Charles F Levenback; Pedro T Ramirez; Judith L Wolf; Carla L Mo 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 404 KB